Image

A Study of Itolizumab (EQ001) to Evaluate the Safety Tolerability PK PD and Clinical Activity in Uncontrolled Asthma

Join our C Trial 1 study today!

Recruiting
18-75 years
All
Phase 1

This study is for people with moderate-to-severe uncontrolled asthma. Asthma is when it's hard to breathe because the airways in the lungs are swollen. The goal is to see if the investigational medication is safe and works well. The study lasts about 12 weeks and includes 5 visits every two weeks to get the medication, plus one follow-up visit.

To join, you should be between 18 and 75 years old, have moderate-to-severe asthma needing daily medication, and have had at least one bad asthma episode in the past year. You cannot join if you smoke, have certain lung diseases, or have had recent serious lung infections.

  • Time Commitment: 12 weeks with 5 visits for medication and 1 follow-up visit.
  • Age Requirement: Must be 18 to 75 years old with moderate-to-severe asthma.
  • Exclusion Factors: Current/former smokers, other lung diseases, or recent lung infections.

If you think you fit the criteria and are interested, talk to your doctor to learn more.

Study details
    Asthma
    Asthma
    Asthma (Pediatric)
    Allergies & Asthma
    Asthma (Pediatric)
    Allergies & Asthma

NCT04007198

Equillium

20 September 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.